Dengvaxia: Philippines Probes Immunization Program Involving Sanofi's Dengue Vaccine That May Pose Health Risks

Earlier recommendations greenlighted administration of Sanofi's Dengvaxia in healthy individuals to prevent dengue fever. Findings of a new long-term study, however, found the dengue vaccine could pose risk to certain individuals.